In today’s rapidly evolving business landscape, mergers and acquisitions (“M&A”) remain a common strategic priority for companies aiming to grow,…
On May 5, 2021, the U.S. Food and Drug Administration (FDA) issued a much-anticipated report, “Resiliency Roadmap for FDA Inspectional…
The most interesting part of this decision by the Fed. Cir. (No. 24- 1061, Aug. 13, 2024) is that the…
On the heels of the rescission of the Fintiv guidance memorandum, the U.S. Patent and Trademark Office has again reshaped…
On Monday September 26, the Department of Justice announced a settlement resolving a lawsuit filed by former employee Michael Bawduniak…
Obviousness-type double patenting (ODP) attempts to prevent the term of a “reference patent” claiming an obvious variant of a parent…
Sign in to your account
Remember me
